Omega Diagnostics Group PLC
04 April 2007
Omega Diagnostics Group PLC
Omega Appoints Fumouze Diagnostics as Distributor for France
Omega Diagnostics Group PLC ('Omega'), the medical diagnostics company,
announces that it has appointed Fumouze Diagnostics ('Fumouze'), part of the
Sofibel SAS group, to act as its distributor for France.
Fumouze will initially sell Omega's Syphilis test product 'IMMUTREP - TPHA' to
infectious diseases and blood bank testing laboratories throughout France.
Created in 1963 and located in Paris, Fumouze is well established and has been
active in the diagnostics sector for over 40 years. Fumouze had a turnover of 10
Million Euros in 2006 and employs 30 staff. It has a customer base of 4,200
private laboratories and 800 hospital laboratories.
Andrew Shepherd, Chief Executive of Omega said, 'This appointment strengthens
our already significant distribution network which covers in excess of 100
countries. Fumouze is a well established company with a successful field-based
sales force. This, together with the ability to promote additional products from
the Omega range, makes Fumouze an excellent partner for success in France'.
Mrs Muriel Le Guern Fellous, General Manager of Fumouze said, 'Based on our
strong presence in the clinical laboratory sector in France and our current
dedicated product lines, we are convinced that the partnership with Omega will
contribute to a better focused service to our customers. We look forward to
actively developing this new business'.
Enquiries:
Omega Diagnostics Group PLC Parkgreen Communications Ltd
Tel: 01259 763030 Paul McManus
Andrew Shepherd, Chief Executive Tel: 020 7479 7933
Kieron Harbinson, Finance Director Mob: 07980 541 893
www.omegadiagnostics.com paul.mcmanus@parkgreenmedia.com
This information is provided by RNS
The company news service from the London Stock Exchange DXGDSLSGGGRX
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.